'Candida auris is also on the World Health Organization’s list of priority pathogens. Last year, it said that there were “only four classes of antifungal medicines currently available, and few candidates [are] in the clinical pipeline. Most fungal pathogens lack rapid and sensitive diagnostics and those that exist are not widely available or affordable globally”.

https://www.ft.com/content/65c36ed2-0fac-479b-9bad-73c471d3929a